Windtree Therapeutics, Inc. (WINT)
NASDAQ: WINT · Real-Time Price · USD
1.560
-0.080 (-4.88%)
At close: Mar 28, 2025, 4:00 PM
1.501
-0.059 (-3.79%)
After-hours: Mar 28, 2025, 7:51 PM EDT
Windtree Therapeutics Stock Forecast
WINT's stock price has decreased by -99.53% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 1 analyst with a 12-month price forecast for Windtree Therapeutics stock has a target of 350, which predicts an increase of 22,335.90% from the current stock price of 1.56.
Analyst Consensus: Hold
* Price targets were last updated on Dec 4, 2024.
Analyst Ratings
According to 1 stock analyst, the rating for Windtree Therapeutics is "Hold". This means that the analyst believes this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 1 | 1 | 1 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates $350 | Hold | Reiterates | $350 | +22,335.90% | Dec 4, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Initiates $900 | Hold | Initiates | $900 | +57,592.31% | Jan 3, 2024 |
| Oppenheimer | Oppenheimer | Buy Initiates $360,000 | Buy | Initiates | $360,000 | +23,076,823.08% | Jun 4, 2021 |
| Ladenburg Thalmann | Ladenburg Thalmann | Strong Buy Initiates $551,250 | Strong Buy | Initiates | $551,250 | +35,336,438.46% | Jun 26, 2020 |
| Stifel | Stifel | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Jun 30, 2017 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
n/a
EPS Next Year
n/a
Revenue Forecast
| Revenue | 2024 | 2025 |
|---|---|---|
| High | n/a | n/a |
| Avg | n/a | n/a |
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2024 | 2025 |
|---|---|---|
| High | - | - |
| Avg | - | - |
| Low | - | - |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -2.50 | -2.24 | -0.64 |
| Avg | -2.43 | -2.17 | -0.62 |
| Low | -2.33 | -2.09 | -0.60 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.